Sign in
4

Changes in Ownership

Editas Medicine, Inc. Filed Acc 0001650664-24-000103

CEO sold 1,555 shares at $3.42 ($5,325)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

O'Neill Gilmore Neil · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-09-04 Sale : show line 1 in the form 10b5-1 −1,555 $3.42 $5,325 313,724 D
Open-market sales · 1,555 sh · avg $3.42 · $5,325
Loading xslF345X05/wk-form4_1725653893.xml…